• Apply To Contribute To London TechWatch
  • Tell Us About Your Startup
  • Email Signup
  • Advertise on London TechWatch
London TechWatch
  • Business
  • Startups
  • Funding
  • Women in Tech
  • London Tech
No Result
View All Result
  • Business
  • Startups
  • Funding
  • Women in Tech
  • London Tech
No Result
View All Result
London TechWatch
No Result
View All Result
Home Uncategorized

Startup Companies to Invest in 2022 – NowRx Could Be a Great Opportunity for Investors

AlleyWatch by AlleyWatch
Share on FacebookShare on Twitter

The tech-powered pharmacy is known for its hassle-free experience and same-day prescription delivery – now you can invest through SeedInvest.

Finding good startup companies to invest in has made venture capitalists billions over the years.

And while getting access to these startups used to require significant wealth and connections, equity crowdfunding platforms like SeedInvest now offer the average investor an opportunity to get in on the action.

For investors that want to dip their toes in and find a good startup company to invest in 2022 – NowRx could be a great opportunity.

NowRx – A Tech Powered Pharmacy for the Future

Founded in Mountain View California, NowRx is a pharmacy chain that uses proprietary tech to provide a more hassle-free experience to customers and same-day delivery – at no additional cost.

In 2021, the startup grew to 8 locations and $25M in annualized revenue while also growing their newest telehealth product by 1,081% from Q1 to Q3. NowRx is off to a hot start in 2022 as well as they have already announced 4 expansion locations (Seattle, Vegas, Denver, and Houston) and several new treatment options for telehealth.

The company’s previous round, a $20M Series B completely sold out and was SeedInvest’s largest raise to date. They are currently in the process of raising a remarkable $73M in equity crowdfunding and still accepting investors for a limited time through SeedInvest.

What makes NowRx special? A system of proprietary pharmacy software, dispensing robotics, and micro-pharmacies that ultimately produce a better customer experience.

It starts with patients or doctors sending a prescription to their local NowRx – the same they would any other pharmacy. However, unlike other pharmacies which largely rely on manual processes and outdated tech, NowRx utilizes its own in-house proprietary pharmacy management software called “QuickFill” and dispensing robots to automatically receive, process, bottle, and dispense prescriptions in under 30 seconds. The company says this dramatically improves the pharmacy’s efficiency, minimizes errors, and frees up pharmacist and technician time.

Once the prescription is ready, NowRx calls the patient to confirm insurance before delivering the prescription in hours for no additional charge.

Both patients and doctors that have used NowRx rave about the pharmacy’s ease of use. At the time of writing, every single NowRx location held a 5-star rating on Yelp, and in a survey of 300 physician office staff, the company received an unprecedented 91 NPS score.

In addition, NowRx’s “QuickFill” technology was recognized this past year with a White Coat Award for Highest Accuracy from SureScripts – the nation’s leading health information network.

How To Invest in NowRx

If you’re looking for startup companies to invest in 2022, NowRx could be a good place to start.

Since the initial equity crowdfunding raise in 2016, NowRx has generated enormous interest from investors with over 10,000 individuals purchasing shares. Over that time, the share price has increased by 1,650% and it looks like there could be significant room for growth.

In addition, InvestorPlace recently highlighted the company as “1 of the 7 Best Startups to Buy Now From Across the Internet”.

Shares in Series C are limited, and the company says they expect to exceed the demand they saw during their sold-out $20M Series B which was the largest equity crowdfunding raise on SeedInvest to date.

If you are interested in learning more about the opportunity to invest, you can download the NowRx Series C pitch deck through their investment page found here.


NowRx is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Tier II of Regulation A. A copy of the Final Offering Circular that forms a part of the Offering Statement may be obtained from: NowRx


 

Previous Post

#Londontech Week in Review: 23/1/29-22/1/22

Next Post

The London TechWatch Startup Daily Funding Report: 31/1/2022

Next Post
The London TechWatch Startup Daily Funding Report: 31/1/2022

The London TechWatch Startup Daily Funding Report: 31/1/2022

ABOUT LONDON TECHWATCH

ABOUT US
ADVERTISE
EDITORIAL GUIDELINES
LEGAL
PRIVACY
TERMS OF USE

CONTACT

ADVERTISE
TIPS
WRITE FOR US

CHANNELS

LONDON VC
LONDON TECH NEWS
LONDON STARTUPS
LONDON TECH DIRECTORY

© 2023 London TechWatch | All Rights Reserved | Proudly Made for London

No Result
View All Result
  • Home
  • Funding
  • London Tech

© 2023 London TechWatch | All Rights Reserved | Proudly Made for London

You are seconds away from signing up for the hottest list in London Tech!

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Close this popup